Legend Biotech Corporation (LEGN) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "LEGN"
      ],
      "issuer_cik": "0001801198",
      "owner_cik": "0001796536",
      "accession_number": "0001796536-26-000010",
      "form_type": "4",
      "filing_date": "2026-10-01",
      "period_of_report": "2026-09-29",
      "issuer_name": "Legend Biotech Corp",
      "issuer_trading_symbol": "LEGN",
      "owner_name": "Sanders Corazon (Corsee) D.",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-29",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 27370,
      "transaction_price_per_share": 9.46,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 52731,
      "transaction_value": 258920.2,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.445 to $9.48 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."
        }
      ]
    },
    {
      "tickers": [
        "LEGN"
      ],
      "issuer_cik": "0001801198",
      "owner_cik": "0002068365",
      "accession_number": "0002068365-26-000005",
      "form_type": "4",
      "filing_date": "2026-07-02",
      "period_of_report": "2026-06-30",
      "issuer_name": "Legend Biotech Corp",
      "issuer_trading_symbol": "LEGN",
      "owner_name": "Casey Patrick John",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-06-30",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 6000,
      "transaction_price_per_share": 14.8,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 48604,
      "transaction_value": 88800,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share)."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.